Approvals
Israel grants approval for SciSparc to start Tourette Syndrome trial
The trial will assess the safety, tolerability, and efficacy of daily oral SCI-110 in Tourette Syndrome adults.
FDA clears Pharmazz’s IND for acute cerebral ischaemic stroke therapy trial
Annovis Bio approved to add further sites for Parkinson’s therapy trial
German regulator approves NeuroSense’s CTA to enrol subjects in ALS trial
MediciNova gains approval from Health Canada for long Covid therapy trial
Gracell receives FDA clearance for multiple myeloma therapy trial
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
